FDA recalls Rugby brand lubricating eye drops nationwide for non-sterility
Rugby brand Polyvinyl Alcohol 1.4% Lubricating Eye Drops are being recalled nationwide due to non-sterility. The recall affects all lots of the 0.5 FL OZ bottles distributed.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: This is an FDA Class I recall, which the rubric identifies as Critical severity. FDA Class I indicates a serious health hazard where non-compliance could cause or contribute to serious adverse health consequences. Non-sterile eye drops present a significant risk of ocular contamination and infection.
Plain-English summary
Rugby brand Polyvinyl Alcohol 1.4% Lubricating Eye Drops, packaged in 0.5 FL OZ (15 mL) bottles, are being recalled nationwide. The product is distributed by Rugby Laboratories in Livonia, Michigan, under National Drug Code (NDC) 0536-1325-94. Approximately 1,492,344 bottles with all lot numbers have been distributed.
The recall is due to non-sterility. Non-sterile eye drops may be contaminated and could cause serious eye infections.
The recall affects all lots distributed nationwide within the United States. Consumers should not use this product.
The recalled product
- Product
- Rugby brand Polyvinyl Alcohol 1.4% Lubricating Eye Drops, packaged in 0.5 FL OZ (15 mL) bottles, Distributed by: Rugby Laboratories, Livonia, MI 48152, NDC 0536-1325-94
- Manufacturer
- Kilitch Healthcare India Limited
- Category
- Drug — Eye drops
- Hazard
- non-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27